FDA Inspection
Recipharm Karlskoga ABRecipharm Karlskoga AB – FDA Inspection, Apr 21, 2023
Record Details
This FDA Inspection record concerns Recipharm Karlskoga AB, with an inspection on April 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Recipharm Karlskoga AB
- Inspection Date
- April 21, 2023
- Product Type
- Drugs
View Company Profile
ID · aa3c0404-0855-4dbe-b3dd-159118f0fd6c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1264910
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Recipharm Karlskoga AB
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Karlskoga AB
- FDA Inspection 1089159 - 2018-03-22
- FDA Inspection 878699 - 2014-05-15
- FDA Inspection 776993 - 2012-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.